Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DeLEPTO Project 1: Preventive Strategies for Complications of Leptospirosis
NCT07127718Phase 2Recruiting
- Sponsor
- National Kidney and Transplant Institute
- Start
- Apr 2024
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in leptospirosis (4 arms), sponsored by National Kidney and Transplant Institute. Primary endpoints: Complement factor I levels at Day 1, Length of hospital stay up to 3 years and 2 more. Started Apr 2024; status: recruiting.
02
Conditions
leptospirosis
Beyond the preview
Go deeper on NCT07127718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07127718.